Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. In ITP, Octagam 10% ...
Several known risk factors of Dermatomyositis (DM ... She is recognized for her contributions to advancing treatment options and understanding of these challenging conditions.
Lundberg agrees: “It would be very interesting to test treatment with IL-6 antibodies in patients with polymyositis, and probably also dermatomyositis.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results